Today: 9 April 2026
Subscribe
Browse Category

ASX:MSB 3 October 2025 - 6 March 2026

Mesoblast Limited shares rise as Ryoncil launch puts $120 million sales target in play

Mesoblast Limited shares rise as Ryoncil launch puts $120 million sales target in play

Mesoblast shares rose 3% in early U.S. trading Friday after the company reported first-half revenue of $51.3 million, up from $3.2 million a year earlier, driven by Ryoncil sales. The company set a fiscal 2026 net revenue target of $110–$120 million for Ryoncil and said 49 transplant centers have been onboarded. Cash stood at $130 million as of Dec. 31. An adult trial for Ryoncil is expected to begin after ethics approval in March.
6 March 2026
·
Australia stock market today: ASX 200 closes higher as tech rebounds; BlueScope pushes back on $13.2b bid

Australia stock market today: ASX 200 closes higher as tech rebounds; BlueScope pushes back on $13.2b bid

The S&P/ASX 200 closed up 0.29% at 8,720.8, led by gains in tech and healthcare, while miners fell. BlueScope rejected a A$13.2 billion takeover bid from SGH and Steel Dynamics. Ansell shares dropped 6.2% as CEO Neil Salmon announced his retirement, with Nathalie Ahlström set to take over in February. The Australian dollar slipped to about 67 U.S. cents.
8 January 2026
·········
Australian Stock Market Today: ASX 200 Climbs 0.8% as Takeover Deals, CPI Shock and Retail Rout Shape 26 November 2025

Australian Stock Market Today: ASX 200 Climbs 0.8% as Takeover Deals, CPI Shock and Retail Rout Shape 26 November 2025

The S&P/ASX 200 rose 0.81% to 8,606.5 Wednesday, shrugging off a jump in annual inflation to 3.8%. Temple & Webster plunged 32% after weak revenue growth, while National Storage REIT surged nearly 20% on a $4 billion takeover bid. The Australian dollar climbed to US$0.6505. Miners and healthcare stocks led gains.
26 November 2025
·········
Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast shares closed at $17.02 on Oct. 2, up 4.6% after the FDA-approved Ryoncil won permanent CMS reimbursement via a new J-code. The company confirmed its cell therapies are made from U.S. donors and not subject to tariffs. Wall Street consensus is “Buy” with a $24 average price target. Hedge funds have increased stakes, but overall institutional ownership remains low.
3 October 2025
··

Stock Market Today

  • Nifty50 Opens Below 23,900; BSE Sensex Drops Over 500 Points Amid Oil Price and US-Iran Ceasefire Worries
    April 9, 2026, 1:20 AM EDT. On April 9, 2026, Indian markets opened lower with Nifty50 falling below 23,900 points and BSE Sensex down over 500 points, pressured by rising oil prices and renewed US-Iran ceasefire concerns. At 9:16 AM, Nifty50 was down 0.59% at 23,857.40, while Sensex slid 0.68% to 77,034.34. Analysts pointed to yesterday's 873-point rally triggered by a two-week ceasefire and crude price drop, but doubts on its durability due to Middle East tensions weighed on sentiment. Despite ongoing foreign portfolio selling, domestic institutional investors supported markets, reflecting cautious optimism. Oil prices edged higher amid supply concerns, while US stocks gained on relief rallies. Investors await clarity on ceasefire talks and upcoming US inflation data, which could influence near-term market direction.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 1:20 AM EDT Nifty50 Opens Below 23,900; BSE Sensex Drops Over 500 Points Amid Oil Price and US-Iran Ceasefire Worries April 9, 2026, 1:20 AM EDT. On April 9, 2026, Indian markets opened lower with **Nifty50** falling below 23,900 points and **BSE Sensex** down over 500 points, pressured by rising oil prices and renewed **US-Iran ceasefire concerns**. At 9:16 AM, Nifty50 was down 0.59% at 23,857.40, while Sensex slid 0.68% to 77,034.34. Analysts pointed to yesterday's 873-point rally triggered by a two-week ceasefire and crude price drop, but
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Go toTop